The US Food and Drug Administration (FDA) has approved LX Sleep®, a software program that calculates an apnea-hypopnea index for diagnosing obstructive sleep apnea from data collected during a home sleep test. Manufactured by NorthEast Monitoring Inc, Maynard, Mass, the equipment consists of the company’s OxyHolter® product and the LX Sleep Software. NorthEast will sell and market the product worldwide.

Related Articles:
Home Testing Product Index